Long-term Follow-up Study of Substance Abuse Screening and Intervention in Multi Primary Care Centers
NCT03452241 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 480
Last updated 2020-03-23
Summary
The purpose of this research is to improve the ability of primary medical staffs in screening and intervention for alcohol, benzodiazepines, and other illicit drug use.
Conditions
- Substance Use
Interventions
- OTHER
-
Intervention Group
The medical staffs who received the training will use the manual of brief intervention to deliver BI and other materials about the harm of substance use.BI refers to a standard 15-30 minute intervention that includes a series of standard models that stimulate knowledge, motivation and behavior that reduce substance abuse.the harm of substance use is a dedicated paper publicity handbook, written by the SHMC, detailing the hazards of substance abuse.
- OTHER
-
Control Group
The participants only receive the materials about the harm of substance use.the harm of substance use is a dedicated paper publicity handbook, written by the SHMC, detailing the hazards of substance abuse.
Sponsors & Collaborators
-
Shanghai Mental Health Center
lead OTHER
Principal Investigators
-
Jiang Du, M.D · Study Principal Investigator Shanghai Mental Health Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-14
- Primary Completion
- 2018-07-10
- Completion
- 2020-03-10
Countries
- China
Study Locations
More Related Trials
-
Acupuncture and the Relaxation Response for Substance Abuse
NCT00375102 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Tolerability and Effects of AZD0530 in Individuals With or Without a Family History of Alcoholism
NCT02262026 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Endotoxin on Alcohol Consumption
NCT04527185 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Alcohol and Drugs of Abuse on Immune Function in Critically Ill Patients With Respiratory Failure
NCT02299921 ·Status: RECRUITING
-
A Pilot, Proof-of-concept Cohort Study of the Prevalence of Comorbid Mental Illness and Substance Abuse
NCT02476877 ·Status: COMPLETED
-
A Long-term Extension Study for the Phase 3 Study of Nalmefene (339-14-001) in Patients With Alcohol Dependence
NCT02382276 ·Status: COMPLETED ·Phase: PHASE3
-
ALK33-005: A Study of ALKS33 (RDC-0313) in Adults With Alcohol Dependence
NCT00981617 ·Status: COMPLETED ·Phase: PHASE2
-
Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)
NCT00453609 ·Status: COMPLETED ·Phase: PHASE4
-
Screening Protocol for the Evaluation of Research Participants at the Maryland Psychiatric Research Center (MPRC)
NCT01030835 ·Status: COMPLETED
-
Screening, Evaluation and Assessment (SEA) Protocol at the NIDA IRP
NCT06552741 ·Status: RECRUITING
-
Longitudinal Changes in the Oral and Gut Microbiome of Individuals With Alcohol Dependence
NCT02911077 ·Status: COMPLETED
-
Effects of Acetate and Alcohol on Brain Function
NCT02542150 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Nalmefene in Patients With Alcohol Dependence
NCT00811941 ·Status: COMPLETED ·Phase: PHASE3
-
Psilocybin-Assisted vs Ketamine-Assisted Psychotherapy for Alcohol Use Disorder
NCT05421065 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Collaborative Care for Alcohol Use Disorders in the Patient-centered Medical Home
NCT02885311 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Naltrexone Treatment for Alcoholic Women
NCT00000448 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of AEF0117 on Treatment-seeking Patients With Cannabis Use Disorder (CUD)
NCT05322941 ·Status: COMPLETED ·Phase: PHASE2
-
SV2A in Older Adults
NCT05465538 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
The Measurement of Mood Variability and Sustained Attention in Women With Alcohol Dependence.
NCT00230425 ·Status: COMPLETED
-
Developing a Novel Human Laboratory Paradigm for AUD Medication Screening
NCT06489782 ·Status: RECRUITING ·Phase: NA
-
An Open Label Trial of Bupropion and Naltrexone for Binge Drinking
NCT02842073 ·Status: COMPLETED ·Phase: PHASE2
-
Human Laboratory Study of ASP8062 for Alcohol Use Disorder
NCT05096117 ·Status: COMPLETED ·Phase: PHASE2
-
Ketamine/Placebo Family History Positive Study
NCT00588952 ·Status: COMPLETED ·Phase: NA
-
Soberlink Within In-Home Addiction Treatment Program
NCT03902171 ·Status: UNKNOWN
-
Clinical Study of Ligustrazine in Treating Alcohol Addiction
NCT05942352 ·Status: RECRUITING ·Phase: PHASE4